The 2026 GLP-1 Buyer’s Guide

Why choosing a GLP-1 provider is harder than it looks

The compounded GLP-1 market exploded in 2024–2026, and dozens of telehealth brands now sell semaglutide and tirzepatide online. On the surface they look similar. Underneath, the differences in pricing structure, billing model, refund policy, and clinical support are enormous — and they are exactly the things marketing pages tend to hide.

This guide gives you a repeatable framework to evaluate any GLP-1 provider in under ten minutes, so you pay a fair price, keep control of your billing, and never get trapped in an auto-renewal you can’t easily cancel.

The 7 questions to ask before you pay

1. Is the full price shown before I create an account? If pricing is hidden behind a quiz or email wall, that is a transparency red flag.

2. Is this a one-time order or an auto-renewing subscription? Auto-renewal is the single most common source of surprise charges in this category.

3. If it is a subscription, can I cancel myself in the portal — or do I have to call or email?

4. Is there a documented money-back guarantee, and what exactly does it cover?

5. Is the clinical evaluation included in the price, or billed as a separate add-on?

6. Where is the pharmacy, and is it a licensed U.S. compounding pharmacy?

7. Is customer support U.S.-based and reachable by more than one channel?

The pricing benchmark

As of 2026, the lowest verifiable starting prices we track in the compounded segment are roughly $83/month for semaglutide and $145/month for tirzepatide. Many well-marketed providers charge $199–$329/month for the same underlying compounded medication.

A price materially above that benchmark is not automatically bad — but it should buy you something real (broader clinical support, faster shipping, a stronger guarantee). If it doesn’t, you are simply paying more for the same molecule.